Human Microbiome Market Scope And Analysis

  • Report Code : TIPBT00002233
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 172
Buy Now

Human Microbiome Market Drivers and Analysis 2031

Buy Now

Human Microbiome Market Report Human Microbiome Market Size and Share Human Microbiome Market Scope and Analysis

Human Microbiome Market Report Scope

Report Attribute Details
Market size in 2023 US$ 1.07 Billion
Market Size by 2031 US$ 4.84 Billion
Global CAGR (2023 - 2031) 20.8%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Product
  • Software and Services
By Application
  • Therapeutics
  • Diagnostics
  • Research
By Disease Type
  • Obesity
  • Diabetes
  • Autoimmune Disorder
  • Cancer
  • GIT Disorders
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • MaaT Pharma
  • Ferring Holdings SA
  • Finch Therapeutics Group Inc
  • AOBiome Therapeutics Inc
  • Seres Therapeutics Inc
  • Merck Co Inc
  • Yakult Honsha Co Ltd
  • Rebiotix Inc
  • IFF Nutrition Biosciences
  • Synthetic Biologics Inc
    		•